Hangzhou Tigermed Consulting (03347) spent 3.2604 million RMB to repurchase 67,000 A shares on January 22nd.
Tiger Pharmaceuticals (03347) announced that it will spend 3.2604 million yuan (RMB) on January 22, 2025.
Hangzhou Tigermed Consulting (03347) announced that on January 22, 2025, it will spend 3.2604 million yuan to repurchase 67,000 shares of A-shares at a repurchase price of 48.54-48.97 yuan per share.
Related Articles
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
